Plasma brain natriuretic peptide assay is valuable in diagnosis of heart failure in the community, as well as in hospital

Plasma brain natriuretic peptide assay is valuable in diagnosis of heart failure in the community, as well as in hospital

Bibliographische Detailangaben
Hauptverfasser:	Davis, R, Hobbs, R, Roalfe, A, Kenkre, J, Hare, R, Davies, M
Format:	Journal article
Veröffentlicht:	2000

Ähnliche Einträge

Plasma N-terminal pro-brain natriuretic peptide has similar predictive value to brain natriuretic peptide in diagnosis of heart failure in the community
von: Hobbs, R, et al.
Veröffentlicht: (2000)

Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations.
von: Hobbs, F, et al.
Veröffentlicht: (2002)

Performance characteristics of N terminal pro brain natriuretic peptide (NT-ProBNP) and BNP assays in the diagnosis of heart failure in community settings
von: Hobbs, R, et al.
Veröffentlicht: (2001)

Performance characteristics of N terminal pro brain natriuretic peptide (NT-proBNP) and BNP assays in the diagnosis of symptomatic and asymptomatic left ventricular systolic dysfunction in primary care
von: Hobbs, R, et al.
Veröffentlicht: (2001)

Mortality of patients in the UK community with left-ventricular systolic dysfunction and heart failure due to other causes
von: Davis, R, et al.
Veröffentlicht: (2003)

Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study.
von: Davis, R, et al.
Veröffentlicht: (2002)

Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population.
von: Hobbs, F, et al.
Veröffentlicht: (2002)

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study.
von: Davies, M, et al.
Veröffentlicht: (2001)

Natriuretic peptide testing and heart failure diagnosis in primary care: diagnostic accuracy study
von: Taylor, CJ, et al.
Veröffentlicht: (2022)

Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004-2018
von: Taylor, C, et al.
Veröffentlicht: (2021)

Survival in patients with prevalent all-cause heart failure and borderline left ventricular systolic dysfunction
von: Hobbs, R, et al.
Veröffentlicht: (2007)

Mortality of patients in England with left ventricular systolic dysfunction and heart failure due to other causes
von: Hobbs, R, et al.
Veröffentlicht: (2005)

Long term trends in natriuretic peptide testing for heart failure in UK primary care: a cohort study
von: Roalfe, A, et al.
Veröffentlicht: (2021)

Natriuretic Peptides in Chronic Heart Failure
von: Hans-Peter Brunner-La Rocca, et al.
Veröffentlicht: (2019-01-01)

Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES).
von: Hobbs, F, et al.
Veröffentlicht: (2007)

Natriuretic peptide-guided treatment for heart failure: a systematic review and meta-analysis
von: McLellan, J, et al.
Veröffentlicht: (2019)

Increased natriuretic peptides not associated with heart failure
von: A. M. Chaulin, et al.
Veröffentlicht: (2021-01-01)

Diagnostic accuracy and clinical impact of natriuretic peptide screening for the detection of heart failure in the community: a protocol for systematic review and meta-analysis
von: Goyder, CR, et al.
Veröffentlicht: (2019)

B-type natriuretic peptide-guided treatment for heart failure
von: McLellan, J, et al.
Veröffentlicht: (2016)

The Predictive Value of Plasma Brain Natriuretic Peptide and Galectin-3 in Elderly Patients Admitted for Heart Failure
von: Marzia Testa, et al.
Veröffentlicht: (2018-09-01)

The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients
von: Mihai Marinescu, et al.
Veröffentlicht: (2023-04-01)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
von: Takekazu Miyoshi, et al.
Veröffentlicht: (2021-03-01)

Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations.
von: Hobbs, F, et al.
Veröffentlicht: (2004)

Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure
von: Antoni Bayes‐Genis, et al.
Veröffentlicht: (2025-02-01)

Natriuretic peptides and chronic heart failure in arterial hypertension patients
von: Yu. A. Vasuyk, et al.
Veröffentlicht: (2007-04-01)

The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
von: Hidetaka Hamasaki
Veröffentlicht: (2016-05-01)

Community prevalence of left ventricular dysfunction and atrial fibrillation, and impact on quality of life
von: Davis, R, et al.
Veröffentlicht: (2000)

Essential components in natriuretic peptide-guided management of heart failure: An intervention synthesis
von: Oke, J, et al.
Veröffentlicht: (2018)

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL
von: A. S. Galjavich, et al.
Veröffentlicht: (2016-01-01)

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL
von: A. S. Galjavich, et al.
Veröffentlicht: (2016-01-01)

Role of Brain Natriuretic Peptide assay in identifying children with pneumonia complicated by congestive cardiac failure
von: Wilson Sadoh, et al.
Veröffentlicht: (2018-12-01)

A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure.
von: Doust, J, et al.
Veröffentlicht: (2004)

Natriuretic Peptide System Activation in Acute Heart Failure Patients with Diabetes
von: Filipe M. Cunha, et al.
Veröffentlicht: (2017-01-01)

B-type natriuretic peptide for diagnosis and treatment of congestive heart failure
von: GM Kuster, et al.
Veröffentlicht: (2002-11-01)

Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure
von: Roberto Licordari, et al.
Veröffentlicht: (2024-03-01)

Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure
von: Shihui Fu, et al.
Veröffentlicht: (2018-01-01)

Natriuretic peptides and Galectin-3 in senile heart failure patients with preserved ejection fraction.
von: Malinova L.I., et al.
Veröffentlicht: (2015-03-01)

Value of mid-regional pro-atrial natriuretic peptide and brain natriuretic peptide for detection of acute heart failure in patients with dyspnea: diagnostic accuracy study
von: Kambiz Masoumi, et al.
Veröffentlicht: (2023-08-01)

The efficacy of different therapy protocols for heart failure in patients with heart failure and increased natriuretic peptide level
von: Kovačević Radmila, et al.
Veröffentlicht: (2009-01-01)

Brain natriuretic peptide as a diagnostic marker for heart failure in hyperthyroid patients with ischemic heart disease
von: Hazem M El-Ashmawy, et al.
Veröffentlicht: (2018-01-01)